Firefly Neuroscience shares are trading higher after the company partners with Zeto to integrate and distribute BNA technology with its EEG device platform.
Portfolio Pulse from Benzinga Newsdesk
Firefly Neuroscience's stock is rising following its partnership with Zeto to integrate and distribute BNA technology with Zeto's EEG device platform.
September 10, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Firefly Neuroscience's stock is experiencing an uptick due to its new partnership with Zeto, which involves integrating BNA technology into Zeto's EEG devices.
The partnership with Zeto is likely to enhance Firefly's product offerings and market reach, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100